Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,847 public trials 2,102 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

NCT03916458

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital San Juan de Dios Manresa, Barcelona, Spain
  • Hospital Parc Taulí de Sabadell Sabadell, Barcelona, Spain
  • Hospital Universitario Mutua Terrassa Terrassa, Barcelona, Spain
View all 31 locations
View Trial Details
Completed

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

NCT02573259

Conditions
Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more
Locations
  • Clinical Research Unit Los Angeles, California, United States
  • Ronald Reagan Medical Center, Department of Radiological Sciences Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
View all 67 locations
View Trial Details
Completed

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

NCT01472081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • City Of Hope Duarte, California, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 14 locations
View Trial Details

Related conditions